DISC MEDICINE INC

IRONNASDAQ

🏆 #1401 by market capEarnings Nov 4US Equity

$81.21▲ $3.04 (+3.74%)

Market closed · at close

1h—

24h▲ 3.7%

7d▲ 2.8%

14d▲ 10.2%

30d▲ 6.9%

1y▲ 37.5%

🏦Market Cap

$3.10B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $80.22 – $81.98
52-Week Range: $40.00 – $99.50
Volume: $2.06B
Avg Volume: $2.59B
Shares Outstanding: 38.2M
Next Earnings: Oct 8, 2026

Fundamentals Snapshot

Annual Revenue: $196M
Last Q Revenue: $53M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-6.57
Dividend Yield: —

Why Investors Own IRON

✓High-growth profile — revenue up +3.3% YoY with expanding US Equity exposure.
✓Healthy economics — 61% gross margin and 8% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$196M▲ +5.8% YoY

Gross Margin (TTM)

61.0%▲ +0.4% YoY

Operating Income (TTM)

$52M▲ +5.8% YoY

Free Cash Flow (TTM)

$15M▲ +5.8% YoY

About DISC MEDICINE INC

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

🦦